Share Name Share Symbol Market Type Share ISIN Share Description
Braveheart Investment Group Plc LSE:BRH London Ordinary Share GB00B13XV322 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 39.00 38.00 40.00 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.3 -0.6 -2.0 - 12

Braveheart Investment Group plc Further update re Paraytec Limited

16/10/2020 7:00am

UK Regulatory (RNS & others)

Braveheart Investment (LSE:BRH)
Historical Stock Chart

From Sep 2020 to Oct 2020

Click Here for more Braveheart Investment Charts.


RNS Number : 2711C

Braveheart Investment Group plc

16 October 2020

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

16 October 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further update re Paraytec Limited

Braveheart Investment Group (AIM: BRH), is pleased to provide an update concerning progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.

As announced on 5 October 2020, proof of concept was achieved for the Optical Detection System. Since then the focus of the Proof of Concept trials have has been on the Capture & Signal Generation Modules.

Braveheart is now pleased to confirm that Proof of Concept has now been achieved for the Capture & Signal Generation Modules, which successfully completes the Proof of Concept trials. The directors of Braveheart believe that this test will be the first to combine a rapid result with very high detection sensitivity. Work will now turn toward the acquisition of clinically relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development. Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data is being sought.

Trevor Brown, CEO Braveheart Investment Group, commented "This is a phenomenal achievement for all concerned. The inspirational leadership and innovative brilliance of Professor Carl Smythe and his talented team have resulted in proof of concept in a little over four months"

 For further information: 
    Braveheart Investment Group plc             Tel: 01738 
    Trevor Brown CEO 
    Allenby Capital Limited (Nominated          Tel: 020 3328 
     Adviser and Joint Broker)                   5656 
    David Worlidge / James Hornigold 
    Peterhouse Capital Limited (Joint Broker)   Tel: 020 7469 
    Heena Karani / Lucy Williams 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 16, 2020 02:00 ET (06:00 GMT)

1 Year Braveheart Investment Chart

1 Year Braveheart Investment Chart

1 Month Braveheart Investment Chart

1 Month Braveheart Investment Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201020 06:22:39